Prolongation of coronavirus outbreak in China could hit Indian pharma sector

China accounted for 67.56 per cent of total imports of bulk drugs and drug intermediates in 2018-19 at USD 2,405.42 million. "The situation is being closely monitored by all companies. The government is seized of the issue and all are working in an integrated way to deal with the situation." Indian Pharmaceutical Alliance (IPA) Secretary General Sudarshan Jain told PTI.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2viJPXM
via IFTTT